Pasurta

Pasurta Special Precautions

erenumab

Manufacturer:

Novartis

Distributor:

DKSH
Full Prescribing Info
Special Precautions
Hypersensitivity Reactions: Serious hypersensitivity reactions, including rash, angioedema, and anaphylactoid reactions, have been reported with Pasurta in post-marketing experience. These reactions may occur within minutes, although some may occur more than one week after treatment. If a serious or severe hypersensitivity reaction occurs, discontinue administration of Pasurta and initiate appropriate therapy [see CONTRAINDICATIONS].
Effects on ability to drive and use machines: Pasurta is expected to have no influence on the ability to drive and use machines.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in